Labcorp Pre-Paid Expenses 2010-2024 | LH

Labcorp pre-paid expenses from 2010 to 2024. Pre-paid expenses can be defined as a current asset created by prepayment of costs and expenses for which the benefits will occur at a future date.
  • Labcorp pre-paid expenses for the quarter ending December 31, 2024 were $0.698B, a 6.46% increase year-over-year.
  • Labcorp pre-paid expenses for 2024 were $0.698B, a 6.46% increase from 2023.
  • Labcorp pre-paid expenses for 2023 were $0.655B, a 7.36% increase from 2022.
  • Labcorp pre-paid expenses for 2022 were $0.61B, a 27.67% increase from 2021.
Labcorp Annual Pre-Paid Expenses
(Millions of US $)
2024 $698
2023 $655
2022 $610
2021 $478
2020 $365
2019 $374
2018 $309
2017 $309
2016 $321
2015 $339
2014 $158
2013 $107
2012 $75
2011 $80
2010 $96
2009 $80
Labcorp Quarterly Pre-Paid Expenses
(Millions of US $)
2024-12-31 $698
2024-09-30 $685
2024-06-30 $618
2024-03-31 $678
2023-12-31 $655
2023-09-30 $700
2023-06-30 $660
2023-03-31 $770
2022-12-31 $610
2022-09-30 $512
2022-06-30 $482
2022-03-31 $516
2021-12-31 $478
2021-09-30 $518
2021-06-30 $462
2021-03-31 $417
2020-12-31 $365
2020-09-30 $327
2020-06-30 $318
2020-03-31 $353
2019-12-31 $374
2019-09-30 $298
2019-06-30 $299
2019-03-31 $317
2018-12-31 $309
2018-09-30 $293
2018-06-30 $286
2018-03-31 $347
2017-12-31 $309
2017-09-30 $450
2017-06-30 $379
2017-03-31 $343
2016-12-31 $321
2016-09-30 $326
2016-06-30 $297
2016-03-31 $360
2015-12-31 $339
2015-09-30 $378
2015-06-30 $387
2015-03-31 $320
2014-12-31 $158
2014-09-30 $126
2014-06-30 $115
2014-03-31 $125
2013-12-31 $107
2013-09-30 $80
2013-06-30 $75
2013-03-31 $67
2012-12-31 $75
2012-09-30 $78
2012-06-30 $68
2012-03-31 $70
2011-12-31 $80
2011-09-30 $78
2011-06-30 $64
2011-03-31 $72
2010-12-31 $96
2010-09-30 $69
2010-06-30 $69
2010-03-31 $74
2009-12-31 $80
2009-09-30 $96
2009-06-30 $68
2009-03-31 $71
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $21.029B $13.009B
Laboratory Corporation of America Holdings or LabCorp is a leading healthcare diagnostics company, providing comprehensive clinical laboratory services and end-to-end drug development support. The provide vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions.
Stock Name Country Market Cap PE Ratio
McKesson (MCK) United States $75.918B 20.77
Becton Dickinson (BDX) United States $66.130B 16.56
Cardinal Health (CAH) United States $30.812B 16.50
Straumann Holding AG (SAUHY) Switzerland $22.515B 0.00
Cooper (COO) United States $17.974B 24.34
West Pharmaceutical Services (WST) United States $15.984B 32.75
Align Technology (ALGN) United States $14.238B 27.05
Henry Schein (HSIC) United States $9.680B 18.44
Merit Medical Systems (MMSI) United States $6.033B 30.81
DENTSPLY SIRONA (XRAY) United States $3.787B 10.30
Patterson (PDCO) United States $2.744B 14.66
CONMED (CNMD) United States $1.915B 14.90
STAAR Surgical (STAA) United States $0.800B 0.00
Lifevantage (LFVN) United States $0.211B 23.38
Pro-Dex (PDEX) United States $0.108B 16.47